Christopher Yasenchak
5PUBLICATIONS
25CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (5)
Sort by Publication Date:
|Dec 29, 2025
Brentuximab vedotin and nivolumab in combination with chemotherapy for nonbulky, early-stage classical Hodgkin lymphoma.Jeremy S Abramson, David J Straus, Nancy L Bartlett
|Jan 08, 2025
Brentuximab Vedotin Combination for Relapsed Diffuse Large B-Cell Lymphoma.Nancy L Bartlett, Uwe Hahn, Won-Seog Kim
|Dec 02, 2024
Brentuximab vedotin, nivolumab, doxorubicin, and dacarbazine for advanced-stage classical Hodgkin lymphoma.Hun Ju Lee, Rod Ramchandren, Judah Friedman
|Nov 10, 2023
Brentuximab vedotin with dacarbazine or nivolumab as frontline cHL therapy for older patients ineligible for chemotherapy.Jonathan W Friedberg, Rodolfo Bordoni, Dipti Patel-Donnelly
|Aug 31, 2023
Real-World Use of Positron Emission Tomography-Computed Tomography and Reported Deauville Scores in Advanced-Stage Classic Hodgkin Lymphoma: A Community Oncology Practice Perspective.Christopher Yasenchak, Nicholas Liu, April Beeks
Pageof 1
Frequent Collaborators
2 joint publications
Hun Ju Lee
2 joint publications
John M Burke
2 joint publications
Nancy L Bartlett
1 joint publications
Jonathan W Friedberg
1 joint publications
Ian W Flinn
1 joint publications
Won-Seog Kim
1 joint publications
Kamel Laribi
1 joint publications
Juan-Miguel Bergua
1 joint publications
Fontanet Bijou
1 joint publications
David MacDonald
